Direkt zum Inhalt
Fachrepositorium Lebenswissenschaften
Freier Zugang zu Wissensressourcen aus den Lebenswissenschaften
Suche
Publisso-Menue
Publizieren
PUBLISSO-System
Bücher
Policy Bücher
Bücher Übersicht
Zeitschriften / Artikel
Journals Übersicht
Serien
Policy Serien
MAK Collection
Kongresse
Forschungsdaten
Repositorien
Fachrepositorium Lebenswissenschaften
Publizieren im Fachrepositorium
LeibnizOpen
Beraten
Forschungsdatenmanagement
Digitale Langzeitarchivierung
Wir für Sie
Volltexte
Filter (Auswahl)
Humans [MeSH]
[x]
Carcinoma, Non-Small-Cell Lung/drug therapy [MeSH]
[x]
Sacherschließung
Lung Neoplasms/drug therapy [MeSH]
(8)
Female [MeSH]
(5)
Lung Neoplasms/pathology [MeSH]
(4)
Carcinoma, Non-Small-Cell Lung/pathology [MeSH]
(3)
Prospective Studies [MeSH]
(2)
Prognosis [MeSH]
(2)
Non-small cell lung cancer
(2)
NSCLC
(2)
Publikationstyp
Artikel
(8)
Medium
Erscheinungsjahr
2021
(6)
2020
(2)
Institution
8 Treffer
Kurzansicht
E-Jahr
Zugriff
Typ
Operations
Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients
2021 .
Purde, Mette-Triin
|
Niederer, Rebekka
|
Wagner, Nikolaus B.
|
Diem, Stefan
|
Berner, Fiamma
|
Hasan Ali, Omar
|
Hillmann, Dorothea
|
Bergamin, Irina
|
Joerger, Markus
|
Risch, Martin
|
Niederhauser, Christoph
|
Lenz, Tobias L.
|
Früh, Martin
|
Risch, Lorenz
|
Semela, David
|
Flatz, Lukas
2021
http://purl.org/ontology/bibo/Article
Crizotinib: aseptic abscesses in multiple organs during treatment of EML4-ALK-positive NSCLC
2021 .
Weber, Daniel
|
Decker, Miriam
|
Schuster, Michael
|
Folz, Sara
|
Stürmer, Carsten Johannes
|
Lutz, Manfred
2021
http://purl.org/ontology/bibo/Article
Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition
2021 .
Unterrainer, Marcus
|
Taugner, Julian
|
Käsmann, Lukas
|
Tufman, Amanda
|
Reinmuth, Niels
|
Li, Minglun
|
Mittlmeier, Lena M.
|
Bartenstein, Peter
|
Kunz, Wolfgang G.
|
Ricke, Jens
|
Belka, Claus
|
Eze, Chukwuka
|
Manapov, Farkhad
2021
http://purl.org/ontology/bibo/Article
Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition
2021 .
Taugner, Julian
|
Käsmann, Lukas
|
Karin, Monika
|
Eze, Chukwuka
|
Flörsch, Benedikt
|
Guggenberger, Julian
|
Li, Minglun
|
Tufman, Amanda
|
Reinmuth, Niels
|
Duell, Thomas
|
Belka, Claus
|
Manapov, Farkhad
2021
http://purl.org/ontology/bibo/Article
Brigatinib versus other second-generation ALK inhibitors as initial treatment of anaplastic lymphoma kinase positive non-small cell lung cancer with deep phenotyping: study protocol of the ABP trial
2021 .
Christopoulos, Petros
|
Bozorgmehr, Farastuk
|
Brückner, Lena
|
Chung, Inn
|
Krisam, Johannes
|
Schneider, Marc A.
|
Stenzinger, Albrecht
|
Eickhoff, Regina
|
Mueller, Daniel W.
|
Thomas, Michael
2021
http://purl.org/ontology/bibo/Article
Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
2021 .
Eichkorn, Tanja
|
Schunn, Fabian
|
Regnery, Sebastian
|
Shafie, Rami El
|
Hörner-Rieber, Juliane
|
Adeberg, Sebastian
|
Herfarth, Klaus
|
Debus, Jürgen
|
König, Laila
2021
http://purl.org/ontology/bibo/Article
Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer
2020 .
Kauffmann-Guerrero, Diego
|
Kahnert, Kathrin
|
Huber, Rudolf M.
2020
http://purl.org/ontology/bibo/Article
Determination of the target population in early benefit assessments in Germany: challenges for non-small-cell lung cancer
2020 .
ten Thoren, C.
|
Balg, C.
|
Gibbert, J.
|
Mostardt, S.
|
Ripoll, M.
|
Schierbaum, D.
|
Schiller, S.
|
Schwalm, A.
2020
http://purl.org/ontology/bibo/Article
